SEC Form 4 · accession 0001125345-17-000033
MACROGENICS INC · MGNX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Thomas Spitznagel
Officer — Sr VP, BPD & Manufacturing
Period of report
Feb 15, 2017
Accepted (ET)
Feb 16, 2017 · 5:45 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001125345
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Common StockF1 | $20.53 | Feb 15, 2017 | A | 45,000 | A | — | Feb 15, 2027 | Common Stock | 45,000 | 45,000 | D |
Explanation of responses
- F112.5% of the options become exercisable 6 months after the date of grant and the remaining 87.5% shall vest in 14 substantially equal quarterly installments thereafter.